Mark E. Dmytruk serves as Executive at Ginkgo Bioworks Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Mark E. Dmytruk has executed 101 insider transactions totaling $3.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 30, 2022 involved exercising options for 16,361 shares valued at $0.
Mark E. Dmytruk currently holds 28,749 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark E. Dmytruk has been a net seller of DNA stock. They have purchased $0 and sold $3.4M worth of shares.
Mark E. Dmytruk's most recent insider trade was on Sep 30, 2022, when they sold 16,361 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted